¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Chronic Lung Disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • Leigh disease
    ¸®º´
  • life style disease
    »ýȰ½À°üº´
  • light chain disease
    °¡º­¿î»ç½½º´, °æ¼âº´
  • lipid storage disease
    ÁöÁúÃàÀûº´
  • liver disease
    °£Áúȯ, °£º´
  • lower motor neuron disease
    ¾Æ·¡¿îµ¿½Å°æ¼¼Æ÷º´, ÇÏÀ§¿îµ¿½Å°æ¿øº´
  • lysosomal storage disease
    ¿ëÇØ¼ÒüÃàÀûº´, ¸®¼ÒÁ»ÃàÀûº´
  • Mikulicz¡¯s disease
    ¹ÌÄð¸®Ä¡º´
  • Minamata disease
    ¹Ì³ª¸¶Å¸º´
  • miner¡¯s disease
    ±¤ºÎº´
  • minimal change disease
    ¹Ì¼¼º¯È­º´
  • malabsorption disease
    Èí¼öÀå¾Öº´
  • mixed connective tissue disease
    È¥ÇÕ°áÇÕÁ¶Á÷º´
  • molecular disease
    ºÐÀÚº´
  • Monge disease
    ¸ùÇ캴
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • mycoplasma disease
    ¹ÌÄÚÇö󽺸¶º´
  • neoplastic disease
    Á¾¾çº´, ½Å»ý¹°º´
  • nervous disease
    ½Å°æº´
  • neurohypophysial disease
    ½Å°æ³úÇϼöüº´
  • neuromuscular disease
    ½Å°æ±ÙÀ°º´
  • neuronal storage disease
    ½Å°æ¼¼Æ÷ÀúÀ庴
  • neuropathic joint disease
    ½Å°æº´Áõ°üÀýº´
  • notifiable disease
    ½Å°í´ë»óÁúº´
  • nutritional disease
    ¿µ¾çº´
  • nutritional deficiency disease
    ¿µ¾ç°áÇ̺´
  • obliterative arterial disease
    Æó»öµ¿¸Æº´
  • obstructive pulmonary disease
    Æó¼âÆóº´
  • occlusive cerebrovascular disease
    Æó¼â³úÇ÷°üÁúȯ
  • occupational disease
    Á÷¾÷º´
  • occupational dental disease
    Á÷¾÷Ä¡°úº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • alpha chain disease
    ¾ËÆÄ¼âÁúȯ
  • alpha-chain disease
    ¾ËÆÄ¼â Áúȯ(¡­áð òðü´)
  • alports syndrome(disease)
    ¾ËÆ÷Æ® ÁõÈıº(º´)(¡­ñøý¦ÏØ)
  • aluminium dust disease
    ¾Ë·ç¹Ì´½°¡·çº´(ÊÙËÓ).
  • alzheimers disease
    ¾ËÂêÇÏÀ̸Ӻ´(¡­Ü»)
  • amaurotic familial idiocy =Tay-Sachs disease
    °¡Á·¼ºÈæ¾Ï½Ã¹éÄ¡(Ê«ðéàõýÙÒ®î¡ÛÜöÁ).
  • amaurotic familial idiocy =Tay-Sachs disease
    °¡Á·¼º Èæ³»Àå ¹éÄ¡(Ê«ðéàõýÙÒ®î¡ÛÜöÁ).
  • amyloid disease
    ¾Æ¹Ð·ÎÀ̵庴(¡­Ü»).
  • andersen disease
    ¾Ø´õ½¼º´<--Áúȯ>
  • angiospasmodic disease
    Ç÷°ü¿¬Ã༺ Áúȯ.
  • aortic valvular disease
    ´ëµ¿¸ÆÆÇÁúȯ(¡­òðü´).
  • aphthous fever =foot and mouth disease
    ¾ÆÇÁŸ¼º¿­(¡­æð).
  • apocrine miliaria => Fox Fordyce disease
    ¾ÆÆ÷Å©¸° ÇÑÁø
  • arbovirus disease
    ¾Æ¸£º¸¹ÙÀÌ·¯½ºº´(¡­Ü»)
  • arthropod-borne viral disease
    ÀýÁöµ¿¹° ¸Å°³ ¹ÙÀÌ·¯½ºº´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • lung maturity
    Æó¼º¼÷µµ
  • lung scaning
    ¹æ»ç ÇÙÀÇÆó½ºÄ³´×.
  • lung surgery
    Æó¿Ü°ú(øËèâΡ).
  • lung thorax compliance
    ÆóÈä°ûź¼º(øËýØü©÷¥àõ), ÆóÈä°ûÀ¯¼øµµ
  • lung thorax compliance
    ÆóÈä°ûź¼º(øËýØü©÷¥àõ).
  • lung transplant
    ÆóÀ̽Ä.
  • lung volume
    Æó¿ë·®
  • lung volume
    Æó¿ë·®(øËé»åÖ), Æó·®.
  • lung volume
    Æó¿ë·®(øËé»åÖ), Æó·®(øËÕá).
  • lung,desquamative interstitial pneumonitis
    ¹Ú¸®¼º °£ÁúÆó·Å(ÚÎ×îàõ ÊÖòðøËæú)
  • lung,diffuse alveolar damage
    ¹Ì¸¸¼º ÆóÆ÷¼Õ»ó( Ø·àõ øËøàáßß¿)
  • lung,diffuse hemorrhagic syndrome
    ¹Ì¸¸¼º ÃâÇ÷¼º ÁõÈıº(¡­ õóúìàõ ñøý¦ÏØ)
  • lung,diffuse interstitial diseaes
    ¹Ì¸¸¼º °£Áú Áúȯ(¡­ Êàòõ òðü´)
  • lung,diseaes
    ȯ( )
  • lung,extralobar sequestration
    ¿±¿Ü ÆóºÐ¸®Áõ(ç¨èâ øËÝÂ×îñø)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
CALD chronic active liver disease
CBDC chronic bullous disease of children
CCVD chronic cerebrovascular disease
CDER Center for Drug Evaluation and Research; chronic granulomatous disease
CDSRF chronic disease and sociodemographic risk factors
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
TBLB Transbroncheal lung biopsy
TBB Transbronchial lung biopsy
TRALI Transfusion-related acute lung injury
EEV end expiratory lung volume
FLM fetal lung maturity
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • hypokinetic disease
    µµÈ¸º´, ¿îµ¿ ºÎÁ· º´
  • idiopathic disease
    Ư¹ßº´
    ´Ù¸¥ ÁúȯÀÇ °á°ú·Î ¹ß»ýÇÏÁö ¾Ê´Â Áúº´À¸·Î¼­, ¿øÀÎÀº ºÒ¸íÀÌ´Ù.
  • immune deficiency disease
    ¸é¿ª °áÇÌ Áúȯ, ¸é¿ª °áÇ̺´
    ¸é¿ª °èÅëÀ» ±¸¼ºÇÏ´Â ¿ä¼ÒÀÇ ±â´É Àå¾Ö¿¡ ÀÇÇÏ¿© ÃÊ·¡µÇ´Â Áúȯ ±º.
  • immunologic disease
    ¸é¿ª Áúȯ, ¸é¿ªÇÐÀû Áúȯ
  • inclusion body disease
    ºÀÀÔü º´
    ¼¼Æ÷ ºÀÀÔü°¡ ³ªÅ¸³ª´Â Áúȯ. ƯÈ÷ ¹ÙÀÌ·¯½º º´¿¡¼­ ÈçÇÏ´Ù.
  • infectious disease
    °¨¿° Áúȯ, °¨¿°¼º Áúȯ, °¨¿°º´, Àü¿°º´
    °¨¿°À» ÀÏÀ¸Å°´Â ¼÷ÁÖ´Â Á¦°¢±â º´¿øÃ¼¿¡ ´ëÇØ¼­ ƯÀ¯ÇÑ ¹ÝÀÀÀ» ³ªÅ¸³»°í ¹ÝÀÀÀÇ º´ÀûÀÎ Á¤µµ¿¡ ´ÞÇØ ÀÓ»ó Áõ»óÀÌ ³ªÅ¸³­ ÁúȯÀ» ¸»ÇÑ´Ù. °¨¿°À» ÀÏÀ¸Äѵµ ¹Ýµå½Ã ¹ßº´ÇÑ´Ù°í´Â ÇÒ ¼ö ¾ø°í ±× º´¿øÃ¼ÀÇ Á¾·ù, º´¿øÃ¼ÀÇ °¨¿°·Â¿¡ °üÇÑ ÀÎÀÚ¿Í °¨¿°ÇÑ »ýüÀÇ °¨¼ö¼º, ¸é¿ª, ±× ¹ÛÀÇ ÀúÇ׷¿¡ °üÇÑ ÀÎÀÚ¿ÍÀÇ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ¼­ °áÁ¤µÈ´Ù.
  • ischemic heart disease
    ÇãÇ÷¼º ½É Áúȯ
  • Jadassohn's disease
    ¾ß´ÙÁ¸ º´
    ¹Ý»ó ±¸Áø»ó È«ÇÇÁõ.
  • Jod-Basedow disease
    Jod-Basedow Áúȯ
    ¿ä¿Àµå À¯¹ß¼ºÀÇ °©»ó¼± ±â´É Ç×ÁøÁõ.
  • jumping disease
    ¹«µµº´
  • Kahler's disease
    Kahler º´
    ´Ù¹ß¼ºÀÇ °ñ¼öÁ¾À¸·Î ÀϹÝÀûÀÎ °ñ ¼¼Æ÷¿¡¼­ º¼ ¼ö ÀÖ´Â Á¾¾ç.
  • Kawasaki disease
    °¡¿Í»çŰ º´
    °©ÀÛ½º·± ¿­°ú Àü½Å¿¡ ¹ßÁøÀÌ ³ªÅ¸³ª´Â ¿øÀÎ ºÒ¸íÀÇ Áúȯ. 1967³â ÀϺ»¿¡¼­ óÀ½À¸·Î º¸°íµÈ µ¥¼­ ÀÌ·± º´¸íÀÌ ºÙ¾ú´Ù. È«¿ª, ¼ºÈ«¿­, dzÁø µî°ú ºñ½ÁÇÑ Áõ¼¼¸¦ º¸À̹ǷΠ°¨º°¿¡ À¯ÀÇÇØ¾ß ÇÑ´Ù. Áõ¼¼·Î´Â, ¨ç °í¿­ÀÌ 5ÀÏ ÀÌ»ó °è¼ÓµÈ´Ù. ¨è ´«ÀÌ ÃæÇ÷µÈ´Ù. ¨é ¼Õ¹Ù´Ú, ¹ß¹Ù´ÚÀÌ »¡°²°Ô ºÎ¾î¿À¸£¸é¼­ ²®ÁúÀÌ ¹þ°ÜÁø´Ù. ¨ê Àӯļ±ÀÌ º×´Â´Ù. ¨ë ÀÔ¼úÀÌ ºÓ¾îÁø´Ù. ¨ì Àü½Å ¹ßÁø Áõ¼¼ µîÀ» º¸À̴µ¥, ÀÌ °¡¿îµ¥ 5°¡Áö ÀÌ»óÀÇ Áõ¼¼¸¦ º¸À̸é ÀÌ º´À» ÀǽÉÇØ¾ß ÇÑ´Ù. ¹ÙÀÌ·¯½º °¨¿°¼³, Áß¼º ¼¼Á¦¼³, Ä­µð´Ù ¼¼±Õ¼³ µîÀÌ ¿øÀÎÀ̶ó´Â Çм³ÀÌ Á¦±âµÇ¾úÀ¸³ª È®½ÇÇÏ°Ô ¹àÇôÁöÁö ¾Ê°í ÀÖ´Ù. 90 % ÀÌ»óÀÌ 1~4¼¼ÀÇ ¿µ, À¯¾Æ±â¿¡ ¹ßº´Çϸç, ¿©¾Æº¸´Ù´Â ³²¾Æ¿¡°Ô ÁÖ·Î ¹ßº´ÇÑ´Ù. ¶ÇÇÑ ¹ßº´·üÀÌ ¼­¾çÀκ¸´Ù µ¿¾çÀο¡°Ô ³ô´Ù. ¿¹¹æ¹ýÀº ÇöÀç µû·Î ¾ø°í Áõ¼¼¸¦ º¸ÀÎ ÈÄ 2~3ÁÖ¸é ÀÚ¿¬ Ä¡À¯µÇ³ª ½ÉÀå ÇÕº´ÁõÀ» ÀÏÀ¸ÄÑ ±Þ»çÇÒ À§ÇèÀÌ ÀÖ´Â Áúº´À̱⵵ ÇÏ´Ù. µû¶ó¼­ Á¶±â¿¡ ¹ß°ßÇÏ¿© ÇÕº´ÁõÀ» ¿¹¹æÇÏ´Â °ÍÀÌ Áß¿äÇÏ´Ù. Çѱ¹¿¡¼­´Â 73³â óÀ½À¸·Î ¹ß°ßµÈ ÀÌ·¡ 91³â 1, 228¸íÀÌ ¹ßº´, º¸°íµÇ¾ú´Ù.
  • Kimura disease
    Ű¹«¶ó º´
    ûÀå³â±âÀÇ ¿©ÀÚ¿¡°Ô ÁÖ·Î ¹ß»ýµÇ´Â ¸Æ¶õ¼º Áõ½Ä¼º º´¼ÒÀÌ´Ù. µÎ°æºÎ ÇÇÇÏ Á¶Á÷À̳ª ±¸°­³» ¶Ç´Â »ó¼ø ³»Ãø¿¡¼­ Àß ¹ß»ýµÇ¸ç ÀÌÇϼ± ºÎÀ§¿¡¼­µµ ÀÚÁÖ º¸ÀδÙ. Á¶Á÷ÇÐÀûÀ¸·Î ÀÌÇü¼º Ç÷°ü ³»ÇÇ ¼¼Æ÷ÀÇ Áõ½Ä°ú ¸¸¼º ¿°Áõ ¼¼Æ÷ÀÇ Ä§À±, È£»ê±¸ÀÇ Ä§À±ÀÌ ÀÖ°í ½ÉÇϸé È£»ê±¸ ³ó¾çµµ Çü¼ºÇÏ¸ç ¸²ÇÁ Á¶Á÷ÀÇ Áõ»óÀ» º¸ÀδÙ. Ÿ¾×¼± Á¶Á÷Àº À§ÃàµÇ°í ÀÖ´Ù.
  • Lane's disease
    ·¹ÀÎ º´
    ¸¸¼º Àå Æó»öÁõ.
  • Langdon-Down's disease
    ·©µ·-´Ù¿î º´
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
lung unit A respiratory bronchiole together with the alveolar ducts and sacs and pulmonary alveoli into which the respiratory bronchiole leads, considered by some to include the terminal bronchiole and its subdivisions, and called a pulmonary acinus.
(05 Mar 2000)
lung ventilation agents <radiology> Xe-133, most commonly used, Xe-127, t = 36.4 days; photons @ 172, 203, 375 keV, can image V after Q, Kr-81m, very expensive, t = 13 sec; photon 190 keV, can repeat V in each projection, Tc-99m DTPA aerosol, can image V in mult. Projections, image Q after V, 1 mCi most likely to be 50-75 mrad to lung, V/Q imaging
(12 Dec 1998)
lung volume measurements Measurement of the amount of air that the lungs may contain at various points in the respiratory cycle.
(12 Dec 1998)
lung window CT settings of window level and width appropriate to showing lung detail; soft tissues are white or nearly so.
Mediastinal window, CT settings of window level and width appropriate to showing soft tissue structures; the lungs become black at these settings.
Synonym: soft tissue window.
(05 Mar 2000)
lymphangitic lung metastases <radiology> Usually adenocarcinoma, breast, lung, upper GI tract (stomach, pancreas)
(12 Dec 1998)
aaa disease Endemic anaemia of ancient Egypt, ascribed in the Papyrus Ebers to intestinal infestation with ancylostoma; now called ancylostomiasis.
(05 Mar 2000)
ABO haemolytic disease of the newborn Erythroblastosis foetalis due to maternal-foetal incompatibility with respect to an antigen of the ABO blood group; the foetus possesses A or B antigen which is lacking in the mother, and the mother produces immune antibody which causes haemolysis of foetal erythrocytes.
(05 Mar 2000)
accumulation disease A disease characterised by abnormal accumulation of a metabolic product in certain cells and tissues; examples include the mucopolysaccharidoses, lipoidoses.
(05 Mar 2000)
Acosta's disease A condition that results from prolonged exposure to high altitude.
Symptoms include a continuous dry cough, shortness of breath, poor exercise tolerance, dizziness, headache, sleep difficulty, anorexia, confusion, fatigue and a rapid pulse.
Treatment includes the immediate movement to a lower altitude. Prophylaxis has been accomplished successfully with the use of acetazolamide (Diamox).
(27 Sep 1997)
acquired immunodeficiency disease Acquired immunodeficiency disease: Disease caused by infection with the human immunodeficiency virus (HIV).
(12 Dec 1998)
acute disease Disease having a short and relatively severe course.
(12 Dec 1998)
Adams-Stokes disease <syndrome> Transient asystole or ventricular fibrillation in the presence of atrioventricular block.
(12 Dec 1998)
Addison-Biermer disease <haematology> A form of anaemia (low red blood cell counts) that results when the bone marrow fails to produce adequate numbers of red blood cells due to a deficiency in vitamin B12. Intrinsic factor, necessary for normal B12 absorption, may be the underlying cause for B12 deficiency if is not produced in the gastric glands (in the stomach).
Origin: Gr. Haima = blood
(27 Sep 1997)
Addison's disease <endocrinology> A rare endocrine disease that results from the underproduction of aldosterone and cortisol (hormones) by the adrenal glands.
Symptoms include weakness, low blood pressure, anaemia, low blood sugar and electrolyte abnormalities.
(27 Sep 1997)
adult-onset still's disease Although Still's disease was first described in children, it is known to begin in adults. See: Still's disease.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
ÅëÇÕ°Ë»ö ¿Ï·á